MSKCC in the News: September 5 – September 18

Posted on September 18, 2013 by Mark

In a recent editorial in Science Translational Medicine MSKCC’s Dr. Clifford A. Hudis discussed how the sequestration is negatively affecting the Food and Drug Administration and slowing the drug approval process.
An open-label Phase I/IIa study at MSKCC showed that d-methadone was safe and well tolerated with 75% of the patients completing the study finding d-methadone to be moderately or very effective.
The addition of surgical oncologist Sam Yoon, MD, and thoracic surgeon Robert Downey, MD, FACS at MSKCC’s outpatient treatment center in Basking Ridge now offers area residents the opportunity to make pre- and post-surgical appointments in a location closer to home.

MSKCC in the News: August 22 – September 4

Posted on September 4, 2013 by Mark

A specific pattern found in the tumor pathology of some patients with lung cancer is a strong predictor of recurrence, according to a new MSKCC study.
MSKCC recently announced the unveiling of a new pressroom and broadcast studio.

Posted on August 21, 2013 by Mark

MSKCC’s Jun-ichi Nitadori and colleagues published the results of a study in the Journal of the National Cancer Institute that showed that the new International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS), and European Respiratory Society (ERS) lung adenocarcinoma classification can be used to predict recurrence after limited resection.
MSKCC researchers have evolved hyperswarming pathogenic bacteria adorned with multiple whipping flagella — all the way down to the molecular level — and plan to unleash them in a laboratory. The findings have been published in Cell Reports.
TVR Communications announced that MSKCC will deploy pCare interactive patient systems.